









Markets
/
Stocks
/
nasdaq-plrz
/

Polyrizon Ltd

PLRZ

View Detailed Chart

1.090USD

0.000

Market hours （ET）Quotes delayed by 15 min

4.57MMarket Cap

--P/E TTM



Polyrizon Ltd

1.090

0.000

Overview Company Financials

Financials

Intraday

30m

Today

0.00%

5 Days

-29.22%

1 Month

+54.76%

6 Months

-11.38%

Year to Date

-49.77%

1 Year

0.00%

View Detailed Chart

Agency Rating

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(3)

Buy(4)

Indicators

Sell(1)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.026

Neutral

RSI(14)

50.236

Neutral

STOCH(KDJ)(9,3,3)

16.946

Sell

ATR(14)

0.358

Low Volatility

CCI(14)

-42.954

Neutral

Williams %R

83.180

Oversold

TRIX(12,20)

3.120

Buy

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

1.302

Sell

MA10

1.368

Sell

MA20

1.098

Sell

MA50

0.877

Buy

MA100

0.652

Buy

MA200

0.925

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..

Ticker SymbolPLRZ

CompanyPolyrizon Ltd

CEOMr. Tomer Izraeli

Websitehttps://polyrizon-biotech.com/